Sign In
Buy CYCN
$3.00
-0.0200 (-0.662%)
At Close: Jun 03, 2026
Research to be presented highlighting potential of neuropsychological biomarkers to guide the clinical development of Cyclerion's investigational therapeutics Research to be presented highlighting pot
Cyclerion Recruits Beacon Biosignals To Identify Disease-Relevant EEG Neurological Biomarkers
06:14am, Friday, 09'th Jul 2021
Cyclerion Therapeutics Inc (NASDAQ: CYCN) and Beacon Biosignals have expanded strategic partnerships between the two companies. This collaboration is expected to identify disease-relevant biomar
Beacon Biosignals and Cyclerion Therapeutics Announce Strategic Partnership
07:22pm, Thursday, 08'th Jul 2021
BOSTON, July 8, 2021 /PRNewswire/ -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies. This
Cyclerion Therapeutics and Beacon Biosignals Announce Expanded Strategic Partnership
04:30pm, Thursday, 08'th Jul 2021
Beacon Biosignals and Cyclerion to extend and expand partnership on data collection and analytics strategy to facilitate development of Cyclerion investigational therapeutics for neurological diseases
Best Penny Stocks on Reddit to Buy? Check These 4 Out in June
09:06am, Tuesday, 15'th Jun 2021
Which penny stocks on Reddit are you watching? Here's 4 for some watchlist inspiration The post Best Penny Stocks on Reddit to Buy?
Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist
02:50pm, Tuesday, 08'th Jun 2021
Meme penny stocks are heating up; are these 3 on your watchlist? The post Meme Penny Stocks Are Here to Stay; 3 For Your Summer Watchlist appeared first on Penny Stocks to Buy, Picks, News and Informa
Cyclerion Therapeutics Announces Global Licensing Agreement with Akebia Therapeutics for Praliciguat
08:00am, Friday, 04'th Jun 2021
Cyclerion eligible to receive up to $585 million in potential future development and commercial milestone payments, and tiered sales-based royalties
Cyclerion Therapeutics Announces Publication of CY6463 Preclinical Data in Frontiers in Pharmacology
04:30pm, Thursday, 27'th May 2021
Series of preclinical studies demonstrate the therapeutic potential of CY6463, a first-in-class, CNS-penetrant sGC stimulator
Cyclerion Therapeutics to Participate in Jefferies Virtual Healthcare Conference
07:00am, Tuesday, 25'th May 2021
CAMBRIDGE, Mass., May 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that Company management will present a corporate overview at the Jefferies Virtual Health
Best Penny Stocks To Buy Right Now? 3 To Know Before Next Week
05:03pm, Friday, 21'st May 2021
After this week's market pullback, some of these penny stocks are trending into the weekend. The post Best Penny Stocks To Buy Right Now?
CYCN Stock: Over 5% Increase Pre-Market Explanation
08:54am, Friday, 07'th May 2021
The stock price of Cyclerion Therapeutics Inc (NASDAQ: CYCN) increased by over 5% pre-market. This is why it happened.
CYCN Stock: Over 3% Increase Pre-Market Explanation
07:25am, Monday, 26'th Apr 2021
The stock price of Cyclerion Therapeutics Inc (NASDAQ: CYCN) increased by over 3% pre-market. This is why it happened.
Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week
01:22pm, Saturday, 24'th Apr 2021
5 Penny Stocks To Watch For The Last Week Of April 2021 The post Best Penny Stocks To Buy Now? 5 For Your Watch List Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | Penn
Cyclerion Therapeutics to Host Pipeline Update Webinar
07:00am, Tuesday, 20'th Apr 2021
Company to discuss clinical updates for CY6463, including Phase 2a studies in ADv and MELAS, and plans to initiate Phase 1b clinical trial in CIAS
Cyclerion Therapeutics Announces Departure of Chief Medical Officer
05:00pm, Thursday, 18'th Mar 2021
CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive f
